Clinical Trials Browser

Phase 2 × Hemangioendothelioma, Epithelioid × 30 days × Clear all

NCT07104331 2026-03-03

SARC046: A Phase II Trial of Nab-Sirolimus in Patients With Progressing or Symptomatic Epithelioid Hemangioendothelioma

Phase 2 Recruiting

Hemangioendothelioma, Epithelioid